PTC Therapeutics | PTCT - PE Price to Earnings


PTC Therapeutics reported 9.98 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Acadia Pharmaceuticals 11.61 2.09 Dec/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amgen 25.31 15.82 Dec/2025
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
Biogen 14.02 4.63 Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Daiichi Sankyo 20.73 1.74 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Gilead Sciences 15.63 0.08 Dec/2025
Incyte 14.84 2.79 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Ironwood Pharmaceuticals 204.24 88.19 Dec/2024
Novartis 15.74 0.15 Sep/2025
Pfizer 14.48 5.18 Dec/2025
PTC Therapeutics 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Roche Holding 16.09 3.51 Dec/2025
Sarepta Therapeutics 27.27 0 Sep/2025
TG Therapeutics 10.76 2.32 Dec/2025
Vertex Pharmaceuticals 26.15 2.22 Dec/2025
Xencor 29.92 3.22 Sep/2022